Custom immune cells tested to fight virus after cancer transplant
NCT ID NCT06391814
Summary
This was a single-patient study testing whether specially grown immune cells from a donor could help control Epstein-Barr virus in a young adult who had a stem cell transplant for lymphoma. Doctors took immune cells from the transplant donor, grew virus-fighting cells in the lab, and gave them to the patient after transplant. The main goal was to see if this approach was safe and could help prevent the virus from causing problems without worsening transplant complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBV ASSOCIATED LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ciusss-Emtl
Montreal, Quebec, H1T 2M4, Canada
Conditions
Explore the condition pages connected to this study.